Using experimental and computational approaches, we showed that the number of CD4+ and CD8+ T cells with positive expression of functional markers, after stimulation with SARS-CoV-2 proteins, could be used to distinguish patients who recovered from COVID-19 from controls and pre-COVID donors, as well as differentiate asymptomatic patients from mild, moderate, and severe patients. This evidence concerns the gene CD8A and COVID-19.